EPISODE · Mar 9, 2026 · 19 MIN
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
from Hematologic Oncology Update
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.CME information and select publications here.
Embed this episode
NOW PLAYING
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
0:00
19:21
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Hematologic Oncology Update?
This episode is 19 minutes long.
When was this Hematologic Oncology Update episode published?
This episode was published on March 9, 2026.
Can I download this Hematologic Oncology Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!